DeBogy Molecular, Inc.
PrivateLast Round
Pre Seed
Nov 19, 2024
Company Overview
DeBogy Molecular, Inc. is a biotechnology company that develops proprietary antimicrobial surface modification technology for medical, industrial, and consumer applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeBogy Molecular, Inc. Comparables
Compare DeBogy Molecular, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genetoo Inc. | 86% | |
| SPARTHA Medical | 86% | |
| Orthobond Corporation | 85% | |
DeBogy Molecular, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Nov 19, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 46% MoM.
- Dec 5, 2024
Grew 71% QoQ, from 7 to 12 employees.
DeBogy Molecular, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DeBogy Molecular, Inc.'s valuation, stock price, and market status.